Deleterious metabolic effects of high fructose intake: The preventive effect of Lactobacillus kefiri administration

Nutrients

Volumn 9, Issue 5, 2017, Pages

  Zubiría, María Guillermina ^a,b   Gambaro, Sabrina Eliana ^a   Rey, María Amanda ^a   Carasi, Paula ^c   Serradell, María de los Ángeles ^c   Giovambattista, Andrés ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR; CYTOKINE; FRUCTOSE; KEFIR;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; BODY WEIGHT; CARBOHYDRATE DIET; CONTROLLED STUDY; EPIDIDYMIS FAT; FIRMICUTES; FOOD INTAKE; GLUCOSE TOLERANCE TEST; HYPERTROPHY; INFLAMMATION; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS KEFIRI; LIPID LIVER LEVEL; MALE; METABOLIC DISORDER; MORPHOMETRY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; QUALITATIVE ANALYSIS; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ADMINISTRATION AND DOSAGE; ANIMAL; BODY WEIGHT GAIN; CALORIC INTAKE; COMPLICATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; OBESITY; PHYSIOLOGY; RANDOMIZATION;

ANIMALS; CYTOKINES; DIETARY CARBOHYDRATES; ENERGY INTAKE; FRUCTOSE; GENE EXPRESSION REGULATION; INFLAMMATION; KEFIR; LACTOBACILLUS; MALE; MICE; OBESITY; PROBIOTICS; RANDOM ALLOCATION; WEIGHT GAIN;

EID: 85019631455     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9050470     Document Type: Article

References (72)

1. Skurk, T.; Alberti-Huber, C.; Herder, C.; Hauner, H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 2007, 92, 1023-1033. [CrossRef] [PubMed]
2. Wåhlen, K.; Sjölin, E.; Löfgren, P. Role of fat cell size for plasma leptin in a large population based sample. Exp. Clin. Endocrinol. Diabetes 2011, 119, 291-294. [CrossRef] [PubMed]
3. Chawla, A.; Nguyen, K.D.; Goh, Y.P.S. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 2011, 11, 738-749. [CrossRef] [PubMed]
4. Lumeng, C.N.; Bodzin, J.L.; Saltiel, A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 2007, 117, 175-184. [CrossRef] [PubMed]
5. Marti, A.; Martinez-González, M.A.; Martinez, J.A. Interaction between genes and lifestyle factors on obesity. Proc. Nutr. Soc. 2008, 67, 1-8. [CrossRef] [PubMed]
6. Malik, V.S.; Popkin, B.M.; Bray, G.A.; Després, J.-P.; Willett, W.C.; Hu, F.B. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: A meta-analysis. Diabetes Care 2010, 33, 2477-2483. [CrossRef] [PubMed]
7. Alzamendi, A.; Zubiría, G.; Moreno, G.; Portales, A.; Spinedi, E.; Giovambattista, A. High Risk of Metabolic and Adipose Tissue Dysfunctions in Adult Male Progeny, Due to Prenatal and Adulthood Malnutrition Induced by Fructose Rich Diet. Nutrients 2016, 8, 178. [CrossRef] [PubMed]
8. Zubiría, M.G.; Fariña, J.P.; Moreno, G.; Gagliardino, J.J.; Spinedi, E.; Giovambattista, A. Excess fructose intake-induced hypertrophic visceral adipose tissue results from unbalanced precursor cell adipogenic signals. FEBS J. 2013, 280, 5864-5874. [CrossRef] [PubMed]
9. Yoo, S.; Ahn, H.; Park, Y.K. High Dietary Fructose Intake on Cardiovascular Disease Related Parameters in Growing Rats. Nutrients 2016, 9, 11. [CrossRef] [PubMed]
10. Cioffi, F.; Senese, R.; Lasala, P.; Ziello, A.; Mazzoli, A.; Crescenzo, R.; Liverini, G.; Lanni, A.; Goglia, F.; Iossa, S. Fructose-Rich Diet Affects Mitochondrial DNA Damage and Repair in Rats. Nutrients 2017, 9, 323. [CrossRef] [PubMed]
11. Zubiría, M.G.; Alzamendi, A.; Moreno, G.; Rey, M.A.; Spinedi, E.; Giovambattista, A. Long-Term Fructose Intake Increases Adipogenic Potential: Evidence of Direct Effects of Fructose on Adipocyte Precursor Cells. Nutrients 2016, 8, 198. [CrossRef] [PubMed]
12. Parks, E.J.; Skokan, L.E.; Timlin, M.T.; Dingfelder, C.S. Dietary sugars stimulate fatty acid synthesis in adults. J. Nutr. 2008, 138, 1039-1046. [PubMed]
13. Samuel, V.T. Fructose induced lipogenesis: From sugar to fat to insulin resistance. Trends Endocrinol. Metab. 2011, 22, 60-65. [CrossRef] [PubMed]
14. Gomes, A.C.; Bueno, A.A.; de Souza, R.G.; Mota, J.F. Gut microbiota, probiotics and diabetes. Nutr. J. 2014, 13, 60. [CrossRef] [PubMed]
15. Nieuwdorp, M.; Gilijamse, P.W.; Pai, N.; Kaplan, L.M. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014, 146, 1525-3153. [CrossRef] [PubMed]
16. Vrieze, A.; Van Nood, E.; Holleman, F.; Salojärvi, J.; Kootte, R.S.; Bartelsman, J.F.W.M.; Dallinga-Thie, G.M.; Ackermans,M.T.; Serlie,M.J.; Oozeer, R.; et al. Transfer of IntestinalMicrobiota FromLean Donors Increases Insulin Sensitivity in IndividualsWithMetabolic Syndrome. Gastroenterology 2012, 143, 913-916. [CrossRef] [PubMed]
17. Arora, T.; Singh, S.; Sharma, R.K. Probiotics: Interaction with gut microbiome and antiobesity potential. Nutrition 2013, 29, 591-596. [CrossRef] [PubMed]
18. De Oliveira Leite, A.M.; Miguel, M.A.L.; Peixoto, R.S.; Rosado, A.S.; Silva, J.T.; Paschoalin, V.M.F. Microbiological, technological and therapeutic properties of kefir: A natural probiotic beverage. Braz. J. Microbiol. 2013, 44, 341-349. [CrossRef] [PubMed]
19. Bourrie, B.C.T.; Willing, B.P.; Cotter, P.D. The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir. Front. Microbiol. 2016, 7, 647. [CrossRef] [PubMed]
20. Nielsen, B.; Gürakan, G.C.; Unlü, G. Kefir: A multifaceted fermented dairy product. Probiotics Antimicrob. Proteins 2014, 6, 123-135. [CrossRef] [PubMed]
21. Garrote, G.L.; Delfederico, L.; Bibiloni, R.; Abraham, A.G.; Pérez, P.F.; Semorile, L.; De Antoni, G.L. Lactobacilli isolated from kefir grains: Evidence of the presence of S-layer proteins. J. Dairy Res. 2004, 71, 222-230. [CrossRef] [PubMed]
22. Hamet, M.F.; Londero, A.; Medrano, M.; Vercammen, E.; Van Hoorde, K.; Garrote, G.L.; Huys, G.; Vandamme, P.; Abraham, A.G. Application of culture-dependent and culture-independent methods for the identification of Lactobacillus kefiranofaciens in microbial consortia present in kefir grains. Food Microbiol. 2013, 36, 327-334. [CrossRef] [PubMed]
23. Golowczyc, M.A.; Mobili, P.; Garrote, G.L.; Abraham, A.G.; De Antoni, G.L. Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis. Int. J. Food Microbiol. 2007, 118, 264-273. [CrossRef] [PubMed]
24. Carasi, P.; Trejo, F.M.; Pérez, P.F.; De Antoni, G.L.; Serradell, M.A. Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins. Anaerobe 2012, 18, 135-142. [CrossRef] [PubMed]
25. Carey, C.M.; Kostrzynska, M. Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium. Can. J. Microbiol. 2013, 59, 9-17. [CrossRef] [PubMed]
26. Hong,W.S.; Chen, H.C.; Chen, Y.P.; Chen, M.J. Effects of kefir supernatant and lactic acid bacteria isolated from kefir grain on cytokine production by macrophage. Int. Dairy J. 2009, 19, 244-251. [CrossRef]
27. Carasi, P. Potencialidad Probiótica de Lactobacilos con Capa S. Estudios sobre la inocuidad, efecto antimicrobiano y capacidad inmunomodulatoria de Lactobacillus kefiri. Ph.D. Thesis, United Nations Laissez-Passer (UNLP), La Plata, Argentina, 2014.
28. Carasi, P.; Díaz, M.; Racedo, S.M.; De Antoni, G.; Urdaci, M.C.; Serradell, M.A. Safety Characterization and Antimicrobial Properties of Kefir-Isolated Lactobacillus kefiri. BioMed Res. Int. 2014, 2014, 208974. [CrossRef] [PubMed]
29. Carasi, P.; Racedo, S.M.; Jacquot, C.; Romanin, D.E.; Serradell, M.A.; Urdaci, M.C. Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J. Immunol. Res. 2015, 2015, 361604. [CrossRef] [PubMed]
30. Garrote, G.L.; Abraham, A.G.; De Antoni, G.L. Chemical and microbiological characterisation of kefir grains. J. Dairy Res. 2001, 68, 639-652. [CrossRef] [PubMed]
31. Perelló, M.; Gaillard, R.C.; Chisari, A.; Spinedi, E. Adrenal enucleation in MSG-damaged hyperleptinemic male rats transiently restores adrenal sensitivity to leptin. Neuroendocrinology 2003, 78, 176-184. [CrossRef] [PubMed]
32. Giovambattista, A.; Gaillard, R.C.; Spinedi, E. Ghrelin gene-related peptides modulate rat white adiposity. Vitam. Horm. 2008, 77, 171-205. [PubMed]
33. Alzamendi, A.; Giovambattista, A.; García, M.E.; Rebolledo, O.R.; Gagliardino, J.J.; Spinedi, E. Effect of pioglitazone on the fructose-induced abdominal adipose tissue dysfunction. PPAR Res. 2012, 2012, 259093. [CrossRef] [PubMed]
34. Alzamendi, A.; Castrogiovanni, D.; Gaillard, R.C.; Spinedi, E.; Giovambattista, A. Increased male offspring’s risk of metabolic-neuroendocrine dysfunction and overweight after fructose-rich diet intake by the lactating mother. Endocrinology 2010, 151, 4214-4223. [CrossRef] [PubMed]
35. Giovambattista, A.; Piermaría, J.; Suescun, M.O.; Calandra, R.S.; Gaillard, R.C.; Spinedi, E. Direct effect of ghrelin on leptin production by cultured rat white adipocytes. Obesity 2006, 14, 19-27. [CrossRef] [PubMed]
36. Malinen, E.; Kassinen, A.; Rinttilä, T.; Palva, A. Comparison of real-time PCR with SYBR Green I or 50-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003, 149, 269-277. [CrossRef] [PubMed]
37. Muyzer, G.; de Waal, E.C.; Uitterlinden, A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 1993, 59, 695-700. [PubMed]
38. Cocolin, L.; Alessandria, V.; Botta, C.; Gorra, R.; De Filippis, F.; Ercolini, D.; Rantsiou, K. NaOH-debittering induces changes in bacterial ecology during table olives fermentation. PLoS ONE 2013, 8, e69074. [CrossRef] [PubMed]
39. Pavel, A.B.; Vasile, C.I. PyElph-A software tool for gel images analysis and phylogenetics. BMC Bioinform. 2012, 13, 9. [CrossRef] [PubMed]
40. Cani, P.D.; Delzenne, N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 2009, 15, 1546-1558. [CrossRef] [PubMed]
41. Drissi, F.; Raoult, D.; Merhej, V. Metabolic role of lactobacilli in weight modification in humans and animals. Microb. Pathog. 2016. [CrossRef] [PubMed]
42. Tilg, H.; Kaser, A. Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Investig. 2011, 121, 2126-2132. [CrossRef] [PubMed]
43. Harper, J.W.; Zisman, T.L. Interaction of obesity and inflammatory bowel disease. World J. Gastroenterol. 2016, 22, 7868. [CrossRef] [PubMed]
44. Vieira, L.Q.; dos Santos, L.M.; Neumann, E.; da Silva, A.P.; Moura, L.N.; Nicoli, J.R. Probiotics Protect Mice Against Experimental Infections. J. Clin. Gastroenterol. 2008, 42, S168-S169. [CrossRef] [PubMed]
45. Lebeer, S.; Vanderleyden, J.; De Keersmaecker, S.C.J. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008, 72, 728-764. [CrossRef] [PubMed]
46. Xu, R.-Y.; Wan, Y.-P.; Fang, Q.-Y.; Lu, W.; Cai, W. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J. Clin. Biochem. Nutr. 2012, 50, 72-77. [CrossRef] [PubMed]
47. Chen, H.-L.; Tung, Y.-T.; Tsai, C.-L.; Lai, C.-W.; Lai, Z.-L.; Tsai, H.-C.; Lin, Y.-L.; Wang, C.-H.; Chen, C.-M. Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. Int. J. Obes. 2014, 38, 1172-1179. [CrossRef] [PubMed]
48. Rosa, D.D.; Grześkowiak, Ł.M.; Ferreira, C.L.L.F.; Fonseca, A.C.M.; Reis, S.A.; Dias, M.M.; Siqueira, N.P.; Silva, L.L.; Neves, C.A.; Oliveira, L.L.; et al. Kefir reduces insulin resistance and inflammatory cytokine expression in an animal model of metabolic syndrome. Food Funct. 2016, 7, 3390-3401. [CrossRef] [PubMed]
49. Ritze, Y.; Bárdos, G.; Claus, A.; Ehrmann, V.; Bergheim, I.; Schwiertz, A.; Bischoff, S.C. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS ONE 2014, 9, e80169. [CrossRef] [PubMed]
50. Zhang, Y.;Wang, L.; Zhang, J.; Li, Y.; He, Q.; Li, H.; Guo, X.; Guo, J.; Zhang, H. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. Eur. J. Nutr. 2014, 53, 221-232. [CrossRef] [PubMed]
51. Machado, M.; Cortez-Pinto, H. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int. J. Mol. Sci. 2016, 17, 481. [CrossRef] [PubMed]
52. Wang, J.; Tang, H.; Zhang, C.; Zhao, Y.; Derrien, M.; Rocher, E.; van-Hylckama Vlieg, J.E.; Strissel, K.; Zhao, L.; Obin, M.; et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 2015, 9, 1-15. [CrossRef] [PubMed]
53. Miyoshi, M.; Ogawa, A.; Higurashi, S.; Kadooka, Y. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur. J. Nutr. 2014, 53, 599-606. [CrossRef] [PubMed]
54. Savcheniuk, O.A.; Virchenko, O.V.; Falalyeyeva, T.M.; Beregova, T.V.; Babenko, L.P.; Lazarenko, L.M.; Demchenko, O.M.; Bubnov, R.V.; Spivak, M.Y. The efficacy of probiotics for monosodium glutamate-induced obesity: Dietology concerns and opportunities for prevention. EPMA J. 2014, 5, 2. [CrossRef] [PubMed]
55. Kim, B.; Park, K.-Y.; Ji, Y.; Park, S.; Holzapfel,W.; Hyun, C.-K. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. Biochem. Biophys. Res. Commun. 2016, 473, 530-536. [CrossRef] [PubMed]
56. Wang, Y.; Xu, N.; Xi, A.; Ahmed, Z.; Zhang, B.; Bai, X. Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl. Microbiol. Biotechnol. 2009, 84, 341-347. [CrossRef] [PubMed]
57. Kawase, M.; Hashimoto, H.; Hosoda, M.; Morita, H.; Hosono, A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J. Dairy Sci. 2000, 83, 255-263. [CrossRef]
58. Cui, C.; Shen, C.J.; Jia, G.; Wang, K.N. Effect of dietary Bacillus subtilis on proportion of Bacteroidetes and Firmicutes in swine intestine and lipid metabolism. Genet. Mol. Res. 2013, 12, 1766-1776. [CrossRef] [PubMed]
59. Iraporda, C.; Romanin, D.E.; Rumbo, M.; Garrote, G.L.; Abraham, A.G. The role of lactate on the immunomodulatory properties of the nonbacterial fraction of kefir. Food Res. Int. 2014, 62, 247-253. [CrossRef]
60. Iraporda, C.; Errea, A.; Romanin, D.E.; Cayet, D.; Pereyra, E.; Pignataro, O.; Sirard, J.C.; Garrote, G.L.; Abraham, A.G.; Rumbo, M. Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells. Immunobiology 2015, 220, 1161-1169. [CrossRef] [PubMed]
61. Gao, Z.; Yin, J.; Zhang, J.; Ward, R.E.; Martin, R.J.; Lefevre, M.; Cefalu, W.T.; Ye, J. Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice. Diabetes 2009, 58, 1509-1517. [CrossRef] [PubMed]
62. Lin, H.V.; Frassetto, A.; Kowalik, E.J.; Nawrocki, A.R.; Lu, M.M.; Kosinski, J.R.; Hubert, J.A.; Szeto, D.; Yao, X.; Forrest, G.; et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 2012, 7, e35240. [CrossRef] [PubMed]
63. Ichimura, A.; Hasegawa, S.; Kasubuchi, M.; Kimura, I. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front. Pharmacol. 2014, 5, 236. [CrossRef] [PubMed]
64. Kimura, I.; Ozawa, K.; Inoue, D.; Imamura, T.; Kimura, K.; Maeda, T.; Terasawa, K.; Kashihara, D.; Hirano, K.; Tani, T.; et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 2013, 4, 1829. [CrossRef] [PubMed]
65. Boutagy, N.E.; McMillan, R.P.; Frisard, M.I.; Hulver, M.W. Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie 2016, 124, 11-20. [CrossRef] [PubMed]
66. Payne, A.N.; Chassard, C.; Lacroix, C. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: Implications for host-microbe interactions contributing to obesity. Obes. Rev. 2012, 13, 799-809. [CrossRef] [PubMed]
67. Di Luccia, B.; Crescenzo, R.; Mazzoli, A.; Cigliano, L.; Venditti, P.;Walser, J.-C.;Widmer, A.; Baccigalupi, L.; Ricca, E.; Iossa, S. Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity. PLoS ONE 2015, 10, e0134893. [CrossRef] [PubMed]
68. Jena, P.K.; Singh, S.; Prajapati, B.; Nareshkumar, G.; Mehta, T.; Seshadri, S. Impact of targeted specific antibiotic delivery for gut microbiota modulation on high-fructose-fed rats. Appl. Biochem. Biotechnol. 2014, 172, 3810-3826. [CrossRef] [PubMed]
69. Mazmanian, S.K.; Round, J.L.; Kasper, D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453, 620-625. [CrossRef] [PubMed]
70. Mazmanian, S.K.; Liu, C.H.; Tzianabos, A.O.; Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122, 107-118. [CrossRef] [PubMed]
71. Haro, C.; Garcia-Carpintero, S.; Alcala-Diaz, J.F.; Gomez-Delgado, F.; Delgado-Lista, J.; Perez-Martinez, P.; Rangel Zuñiga, O.A.; Quintana-Navarro, G.M.; Landa, B.B.; Clemente, J.C.; et al. The gut microbial community in metabolic syndrome patients is modified by diet. J. Nutr. Biochem. 2016, 27, 27-31. [CrossRef] [PubMed]
72. Tang, C.; Kamiya, T.; Liu, Y.; Kadoki, M.; Kakuta, S.; Oshima, K.; Hattori, M.; Takeshita, K.; Kanai, T.; Saijo, S.; et al. Inhibition of Dectin-1 Signaling Ameliorates Colitis by Inducing Lactobacillus-Mediated Regulatory T Cell Expansion in the Intestine. Cell Host Microbe 2015, 18, 183-197. [CrossRef] [PubMed]